glp 1 agonists and sglt2 inhibitors vs. GLP-1 to Treat the Heart, the Kidneys the Brain Cardiorenal Protection: Potential of SGLT2

Treatment requires monitoring of renal function, HbA1c, and body weight, with SGLT2 inhibitors temporarily discontinued during acute illness or before major surgery

Accessed at pubmed.ncbi.nlm.nih.gov/21844879

Tail vein blood glucose concentrations were measured using a handheld glucometer (Contour XT, Bayers) at 0, 15, 30, 60 and 120 min after injection

On the basis of these findings, the overall efficacy and safety of tirzepatide has been investigated in the SURPASS clinical trial programme in comparison with placebo and other glucose-lowering medications including GLP-1 RAs and basal insulin [11]

[DOI] [PubMed] [Google Scholar] 99.Graaf C., et al

"So, the recommendation currently is to stop the medication prior to conception," Maya said